A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.
about
Overview of guidelines for the management of dyslipidemia: EU perspectivesCurrent practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation methodAtherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study.Cholesteryl ester transfer protein inhibitors: challenges and perspectives.Pharmacological management of diabetic dyslipidemia.Hypertriglyceridaemia and risk of coronary artery disease.Lipid testing in infectious diseases: possible role in diagnosis and prognosis.Cardiovascular disease prevention strategies for type 2 diabetes mellitus.ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.Spectrophotometry and Ultracentrifugation for Measurement of Plasma Lipids in Dogs with Diabetes Mellitus.Fibrates in the management of atherogenic dyslipidemia.Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin
P2860
Q28069411-49CF6571-19EA-4C44-9461-4C89DD1F88D8Q33646780-BE57CCA0-8FB1-445E-A705-F74D77C78F07Q33803712-E603DAAE-24BB-4B75-A700-B645752BD19CQ37119482-5B35EDED-17C1-4BA5-B3CB-46F636D1CA17Q38832774-DE61746B-88BD-467C-A38D-4732C712B50EQ39015072-12A804B7-6E4A-473B-83AD-EE5B56C1D5E8Q39181612-33FEA622-6C54-4535-94D1-44ED86F93BDCQ39293001-9FA09567-077F-4CB4-9BB4-A55A8F66DD5CQ39420208-34BF5822-35EB-4D1C-AECC-13590F93BC99Q40104818-A82241A8-3D30-492B-B627-53BC23FFAB72Q48202587-4AFD566B-7505-47B2-8532-A9ED1E9113E1Q49571281-068A2324-5876-49EC-9B76-D92219206E64Q57050380-8D559811-1584-4ABC-B933-7346EAC8D829
P2860
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A review of the evidence on re ...... te-statin combination therapy.
@en
type
label
A review of the evidence on re ...... te-statin combination therapy.
@en
prefLabel
A review of the evidence on re ...... te-statin combination therapy.
@en
P2093
P50
P1476
A review of the evidence on re ...... ate-statin combination therapy
@en
P2093
Alberto Mello E Silva
Alberto Zambon
Carlos Aguiar
Eduardo Alegria
Jesus Millan
José Luis Zamorano
Lale Tokgozoglu
Margus Viigimaa
Meral Kayikcioglu
Michel Farnier
P356
10.1016/S1567-5688(15)30001-5
P50
P577
2015-09-01T00:00:00Z